Cargando…

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma

Detalles Bibliográficos
Autores principales:	Pietrobono, Silvia, Stecca, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219654/ https://www.ncbi.nlm.nih.gov/pubmed/37235835 http://dx.doi.org/10.18632/oncotarget.28441

Ejemplares similares

Regulation of melanoma initiating cells by Hedgehog signaling and SOX2
por: Santini, Roberta, et al.
Publicado: (2014)

Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
por: Pietrobono, Silvia, et al.
Publicado: (2019)

Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe
por: Pietrobono, Silvia, et al.
Publicado: (2018)

Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
por: Pietrobono, Silvia, et al.
Publicado: (2021)

MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary Ciliogenesis
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
por: Pietrobono, Silvia, et al.
Publicado: (2018)

The Role of Glycosylation in Melanoma Progression
por: De Vellis, Chiara, et al.
Publicado: (2021)

The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway
por: Stecca, Barbara, et al.
Publicado: (2002)

SOX2 as a novel contributor of oxidative metabolism in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2018)

Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy
por: Pandolfi, Silvia, et al.
Publicado: (2015)

Emerging Roles of Hedgehog Signaling in Cancer Immunity
por: Giammona, Alessandro, et al.
Publicado: (2023)

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Novel Therapeutic Targets in Melanoma
por: Cerezo, Michaël, et al.
Publicado: (2023)

Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
por: Raymond, Jérémy H., et al.
Publicado: (2022)

Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
por: Maresca, Luisa, et al.
Publicado: (2022)

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells
por: Tusa, Ignazia, et al.
Publicado: (2021)

The Role of the Hedgehog Pathway in Cholangiocarcinoma
por: Anichini, Giulia, et al.
Publicado: (2021)

Role of Protein Kinases in Hedgehog Pathway Control and Implications for Cancer Therapy
por: Montagnani, Valentina, et al.
Publicado: (2019)

Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas
por: Abidi, Afroz
Publicado: (2014)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
por: Montagnani, Valentina, et al.
Publicado: (2015)

HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth
por: Pandolfi, S, et al.
Publicado: (2015)

p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells
por: Pietrobono, Silvia, et al.
Publicado: (2022)

Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”
por: Carè, Alessandra, et al.
Publicado: (2022)

BETter together: exploiting BRD4-functions in transcription to inform rational combinations
por: Savarese, Fabio, et al.
Publicado: (2018)

Gli2, hedgehog and TCR signalling
por: Furmanski, Anna L., et al.
Publicado: (2015)

Hedgehog Signaling in Organogenesis and the Tumor Microenvironment
por: Shimo, Tsuyoshi
Publicado: (2020)

BRD4: An emerging prospective therapeutic target in glioma
por: Yang, Hua, et al.
Publicado: (2021)

BRD4 as a Therapeutic Target in Pulmonary Diseases
por: Guo, Xia, et al.
Publicado: (2023)

Hedgehog and WNT Signaling Hubs in Tracheal Morphogenesis
por: Frank, David B., et al.
Publicado: (2019)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor
por: Liu, Na, et al.
Publicado: (2022)

SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
por: Santini, R, et al.
Publicado: (2014)

Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis
por: Zhubanchaliyev, Altynbek, et al.
Publicado: (2016)

The Role of Hedgehog Signaling in the Melanoma Tumor Bone Microenvironment
por: Shamsoon, Karnoon, et al.
Publicado: (2023)

Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
por: Zuo, M, et al.
Publicado: (2015)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer
por: Matsushita, Shojiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ldku048jb318jmv0gatqeg3070